Smart move by Anteotech to move quickly , The findings below is why A decision has been made to halt the EuGeni SARS-CoV-2 Ag RDT1 European clinical trial and divert resources and funding from the trial to enable the acceleration of the COVID19 Flu A / Flu B Multiplex and/or other Point of Care (POC) tests currently being considered by AnteoTech’s New Product Council.
News >
WebMD Health NewsIs It Flu, RSV or COVID? Experts Fear the ‘Tripledemic’Kathleen Doheny
October 26, 2022
Just when we thought this holiday season, finally, would be the back-to-normal one, some infectious disease experts are warning that a so-called tripledemic – influenza, COVID-19, and RSV – may be in the forecast.
The warning isn’t without basis.
For COVID-19, some models are predicting some spikes before Christmas, he says, and others see a new wave in 2023. For the flu, the model is predicting an earlier-than-usual start, as the CDC has reported.
While flu activity is relatively low, the CDC says, the season is off to an early start. For the week ending Oct. 21,
1,674 patients were hospitalized for flu, higher than in the summer months but fewer than the 2,675 hospitalizations for the week of May 15, 2022.
As of Oct. 20, COVID-19 cases have declined 12% over the last 2 weeks, nationwide. But hospitalizations are up 10% in much of the Northeast,
The New York Times reports, and the improvement in cases and deaths has been slowing down.
As of Oct. 15,
15% of RSV tests reported nationwide were positive, compared with about 11% at that time in 2021, the CDC says. The surveillance collects information from 75 counties in 12 states.
